Messina Roberta - San Raffaele Scientific Institute, Vita-Salute San Raffaele University Milan Italy

基本信息

浏览量：15

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 128 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Evaluating the Effectiveness, Tolerability, and Safety of Eptinezumab in High-Frequency and Chronic Migraine in Real World: EMBRACE—The First Italian Multicenter, Prospective, Real-Life Study

Piero Barbanti,Bianca Orlando,Gabriella Egeo,Florindo d'Onofrio,Alberto Doretti,Stefano Messina,Massimo Autunno,Roberta Messina,Massimo Filippi,Giulia Fiorentini, Cristina Rotondi,Stefano Bonassi,Cinzia Aurilia

BRAIN SCIENCESno. 7 (2024)

引用0浏览0WOS引用

Effectiveness and Safety of Monthly Versus Quarterly Fremanezumab for Migraine Prevention: an Italian, Multicenter, Real-Life Study

Laura Zanandrea,Roberta Messina,Ilaria Cetta, Federica Genovese,Simone Guerrieri,Fabrizio Vernieri,Claudia Altamura,Sabina Cevoli,Valentina Favoni,Bruno Colombo,Massimo Filippi

EUROPEAN JOURNAL OF NEUROLOGY (2024)

引用0浏览0WOS引用

Influence of Next-Generation Artificial Intelligence on Headache Research, Diagnosis and Treatment: the Junior Editorial Board Members’ Vision – Part 1

Igor Petrušić, Woo-Seok Ha,Alejandro Labastida-Ramirez,Roberta Messina,Dilara Onan, Claudio Tana, Wei Wang

The Journal of Headache and Painno. 1 (2024): 1-12

引用0浏览0WOS引用

Efficacy and Safety of Anti-Cgrp Monoclonal Antibodies for Chronic Migraine Prophylaxis in Patients Treated with Botulinum Toxin A: A Prospective Monocentric Study

Calogera Butera,Ilaria Cetta,Roberta Messina, Laura Zanandrea,Roberto Santangelo,Bruno Colombo,Massimo Filippi,Ubaldo Del Carro

Cephalalgia Reports (2024)

引用0浏览0引用

Erenumab effect on brain network function in episodic migraine patients: a randomized, placebo-controlled, clinical trial

Roberta Messina,Marta Bartezaghi,Ilaria Cetta,Bruno Colombo,Licia Grazzi,Daniele Martinelli,Raffaele Ornello,Anna Pichiecchio,Debora Raimondi,Maria Assunta Rocca,Antonio Russo,Simona Sacco,Alessandra Splendiani,Cristina Tassorelli,Renato Turrini,Paola Valsasina,Massimo Filippi

CEPHALALGIAno. 1supp (2023): 256-257

引用0浏览0引用

Is there a sustained response following discontinuation of long-lasting anti-CGRP monoclonal antibodies treatment

I. Cetta,R. Messina,L. Zanandrea,S. Guerrieri,G. Vaghi,R. De Icco,G. Sances,B. Colombo, M. Filippi

EUROPEAN JOURNAL OF NEUROLOGY (2023): 153-153

引用0浏览0引用

Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials

Faraidoon Haghdoost,Francesca Puledda,David Garcia-Azorin,Eva-Maria Huessler,Roberta Messina,Patricia Pozo-Rosich

CEPHALALGIA（2023）

引用15浏览0WOS引用

International availability of headache medications - an ongoing global survey of the International Headache Society

Francesca Puledda,Irene de Boer,David Garcia-Azorin,Roberta Messina,Mohammad Al-Mahdi Al-Karagholi,Marcio Nattan Portes Souza,Olivia Begasse de Dhaem, Maria-Teresa Goicochea,Cristina Tassorelli,Arne May

CEPHALALGIA（2023）

引用0浏览0引用

Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis

Roberta Messina,Eva-Maria Huessler,Francesca Puledda,Faraidoon Haghdoost,Elena R. Lebedeva,Hans-Christoph Diener

Cephalalgia（2023）

引用23浏览0WOS引用

What imaging has revealed about migraine and chronic migraine

Roberta Messina,Massimo Filippi

Handbook of clinical neurology (2023): 105-116

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn